PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 60% of sites...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.02 | -1.33333333333 | 1.5 | 1.58 | 1.46 | 232819 | 1.50227 | CS |
4 | -0.08 | -5.12820512821 | 1.56 | 1.66 | 1.46 | 209235 | 1.53582124 | CS |
12 | -0.09 | -5.73248407643 | 1.57 | 1.75 | 1.4 | 226131 | 1.55604378 | CS |
26 | -0.21 | -12.426035503 | 1.69 | 2.26 | 1.4 | 361072 | 1.73390486 | CS |
52 | -4.78 | -76.357827476 | 6.26 | 6.66 | 1.175 | 519484 | 2.04929927 | CS |
156 | -27.74 | -94.9349760438 | 29.22 | 30.48 | 1.175 | 639909 | 10.00168966 | CS |
260 | -33.57 | -95.7774607703 | 35.05 | 63.22 | 1.175 | 546161 | 13.01511176 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.